How the Direct Oral Anticoagulant Apixaban Affects Thrombin Generation Parameters. Issue 6 (June 2015)

• Record Type: Journal Article
• Authors: Tripodi, Armando; Padovan, Lidia; Veena, Chantarangkul; Scalambrino, Erica; Testa, Sophie; Peyvandi, Flora
• Is Part Of: Thrombosis research. Volume 135:Issue 6(2015)
• Page Start: 1186
• Page End: 1190
• Publication Date: 2015-06
• Subjects: Anticoagulants -- Thrombosis -- Thrombomodulin -- Prothrombin time -- Partial thromboplastin time; Thrombosis -- Periodicals; 616.135
• DOI: 10.1016/j.thromres.2015.03.032
• Languages: English
• ISSNs: 0049-3848

Abstract

Abstract: Background and objectives: Apixaban is a direct oral anticoagulant (DOAC) targeting factor Xa and thus quenching thrombin generation and clot formation. However, little information is available on the influence that apixaban may have on the parameters of thrombin generation. Methods: Aliquots of a pooled normal plasma have been added with increased concentrations of purified apixaban and were used to assess the degree of modification brought about by the drug on the basic tests of coagulation prothrombin and activated partial thromboplastin time (PT and APTT) and on thrombin generation parameters. Results: The study shows that while apixaban has little effect on PT or APTT it does affect all the parameters of thrombin generation, including the lag-time (which is increased), the endogenous thrombin potential (ETP) and thrombin-peak (both decreased although to a different extent), and the velocity index (decreased). Interestingly, the above effects were more pronounced when the measurements were recorded in the presence of thrombomodulin, thus making the ratio (with/without thrombomodulin) to decrease consistently as a function of the apixaban concentrations. Conclusions: These findings support the antithrombotic properties of apixaban and can help to understand the mechanism(s) of action of this drug. Thrombin generation could be used as a convenient laboratory tool to assess the anticoagulant activity of other drugs and to make between-DOAC comparison. Highlights: The anticoagulant effect of apixaban was evaluated in plasmas spiked with the drug. Apixaban has little effect on PT or APTT Apixaban does affect all the parameters of thrombin generation Lag-time (increased); ETP, thrombin-peak and velocity index (decreased). The effects were more pronounced in the presence of thrombomodulin.